Teva Is Latest To Be Hit With DOJ Suit Over Charity Copays
Executive Summary
Government claims Teva’s payments to two foundations to cover Copaxone copays violated Anti-Kickback statute. Teva is bucking settlement trend in DOJ’s industrywide investigation of sponsor ties to charitable foundations.
You may also be interested in...
Why Is Congress Targeting These Six Medicines In Drug Price Hearing?
Revlimid, Copaxone, Sensipar, Enbrel, Acthar Gel and Gleevec will be the subject of a US House Committee on Oversight and Reform in an upcoming drug price hearing.
Teva Gambles Indictment Is Better Than Pleading Guilty To US Price-Fixing Claims
Teva’s market overhang and legal uncertainty intensifies with DOJ charges it conspired to fix generic drug prices. Five other companies have pled guilty and reached deferred prosecution agreements.
Teva Gambles Indictment Is Better Than Pleading Guilty To Price-Fixing Claims
Teva’s market overhang and legal uncertainty intensifies with DOJ charges it conspired to fix generic drug prices. Five other companies have pled guilty and reached deferred prosecution agreements.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: